High Dietary Fructose Intake on Cardiovascular Disease Related Parameters in Growing Rats

Nutrients. 2016 Dec 26;9(1):11. doi: 10.3390/nu9010011.

Abstract

The objective of this study was to determine the effects of a high-fructose diet on cardiovascular disease (CVD)-related parameters in growing rats. Three-week-old female Sprague Dawley rats were randomly assigned to four experimental groups; a regular diet group (RD: fed regular diet based on AIN-93G, n = 8), a high-fructose diet group (30Frc: fed regular diet with 30% fructose, n = 8), a high-fat diet group (45Fat: fed regular diet with 45 kcal% fat, n = 8) or a high fructose with high-fat diet group (30Frc + 45Fat, fed diet 30% fructose with 45 kcal% fat, n = 8). After an eight-week treatment period, the body weight, total-fat weight, serum glucose, insulin, lipid profiles and pro-inflammatory cytokines, abdominal aortic wall thickness, and expressions of eNOS and ET-1 mRNA were analyzed. The result showed that total-fat weight was higher in the 30Frc, 45Fat, and 30Frc + 45Fat groups compared to the RD group (p < 0.05). Serum triglyceride (TG) levels were highest in the 30Frc group than the other groups (p < 0.05). The abdominal aorta of 30Frc, 45Fat, and 30Frc + 45Fat groups had higher wall thickness than the RD group (p < 0.05). Abdominal aortic eNOS mRNA level was decreased in 30Frc, 45Fat, and 30Frc + 45Fat groups compared to the RD group (p < 0.05), and also 45Fat and 30Frc + 45Fat groups had decreased mRNA expression of eNOS compared to the 30Frc group (p < 0.05). ET-1 mRNA level was higher in 30Frc, 45Fat, and 30Frc + 45Fat groups than the RD group (p < 0.05). Both high fructose consumption and high fat consumption in growing rats had similar negative effects on CVD-related parameters.

Keywords: cardiovascular disease (CVD); growing rat; high fructose diet.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Body Weight
  • Cardiovascular Diseases / physiopathology*
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Diet, High-Fat
  • Dietary Carbohydrates / administration & dosage
  • Dietary Fats / administration & dosage
  • Dietary Proteins / administration & dosage
  • Energy Intake
  • Female
  • Fructose / administration & dosage*
  • Fructose / adverse effects
  • Insulin / blood
  • Interleukin-6 / blood
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism
  • Plasminogen Activator Inhibitor 1 / blood
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Triglycerides / blood
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Dietary Carbohydrates
  • Dietary Fats
  • Dietary Proteins
  • Insulin
  • Interleukin-6
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Fructose
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat